semaglutide cancer cases GLP-1 use linked to lower breast incidence in large cohort study Ozempic's Dirty Secret: Exposing the

All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Application: Injection Sites : Common sites for IM injections include the deltoid muscle (upper arm), the gluteus maximus (buttocks), and the vastus lateralis (thigh)

Some authors note that PDMM may be associated with neurocutaneous syndromes such as neurocutaneous melanosis syndrome, Sturge-Weber syndrome, and neurofibromatosis type I [17]

2017 Wilding JPH, Batterham RL, Calanna S, et al